Case Report: Post-traumatic splenosis and potential pitfall for PSMA-PET
Background18F-prostate specific membrane antigen (PSMA) PET is fast becoming the gold-standard in prostate cancer, both in staging of intermediate-/high-risk patients and in re-staging patients with biochemical failure. Several pitfalls of 18F-PSMA PET have been reported, and we report, to our best...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2023-11-01
|
| Edice: | Frontiers in Nuclear Medicine |
| Témata: | |
| On-line přístup: | https://www.frontiersin.org/articles/10.3389/fnume.2023.1319952/full |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|